We suggest that the results and RGC‐based prognostic model developed in the present study probably reflect the essential pathobiological processes in early‐stage MYC‐driven malignization in AT liver cells, which consequently affect tumor progression and poor OS of HCC patients. The gene discussed is MYC; the disease is neoplasm.